Ultragenyx Pharma (RARE) PT Lowered to $70 at Baird; Multiple Milestones Ahead

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to Ultragenyx Pharma (RARE) PT Lowered to $70 at Baird; Multiple Milestones Ahead

Ultragenyx Pharma (RARE) PT Lowered to $70 at JMP Securities

February 21, 2018 4:35 AM EST

JMP Securities lowered its price target on Ultragenyx Pharma (NASDAQ: RARE) to $70.00 (from $80.00) while maintaining a Market Outperform rating.

... More

Ultragenyx Pharma (RARE) PT Lowered to $74 at Stifel

February 21, 2018 3:32 AM EST

Stifel lowered its price target on Ultragenyx Pharma (NASDAQ: RARE) to $74.00 (from $85.00) while maintaining a Buy rating.

... More

Ultragenyx Pharma (RARE) Tops Q4 EPS by 10c

February 20, 2018 4:12 PM EST

Ultragenyx Pharma (NASDAQ: RARE) reported Q4 EPS of ($1.89), $0.10 better than the analyst estimate of ($1.99).

For earnings history and earnings-related data on Ultragenyx Pharma (RARE) click here.

... More